paperKB
coga / coga-kb
Help
Sign in
C

Cardon, Lon R

Alternative Discovery and Development, GlaxoSmithKline, Upper Merion, Pennsylvania, USA

TitleYearPMID
The support of human genetic evidence for approved drug indications. 2015 26121088
Use of genome-wide association studies for drug repositioning. 2012 22491277
Optimizing the power of genome-wide association studies by using publicly available reference samples to expand the control group. 2010 20088020
Finding the missing heritability of complex diseases. 2009 19812666
Marker selection for genetic case-control association studies. 2009 19390530
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. 2008 18587394
Genome-wide association studies for complex traits: consensus, uncertainty and challenges. 2008 18398418
A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. 2007 17434869
A second generation human haplotype map of over 3.1 million SNPs. 2007 17943122
Designing candidate gene and genome-wide case-control association studies. 2007 17947991
Replicating genotype-phenotype associations. 2007 17554299
Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. 2007 17463249
Evaluating coverage of genome-wide association studies. 2006 16715099
Genetics. Delivering new disease genes. 2006 17138888
Population stratification and spurious allelic association. 2003 12598158
Merlin--rapid analysis of dense genetic maps using sparse gene flow trees. 2002 11731797
Showing 1–16 of 16